Pulike Biological Engineering
SSE · 603566
Market Cap$3.6B
Revenue$1.1B
Employees1519
Listed OnSSE
Ticker603566
CEO / ExecMr. Wei Hu
HeadquartersLuoyang
MarketMainland China
Websitewww.pulike.com.cn
Overview
Pulike Biological Engineering, Inc. engages in the research, development, production, and sale of veterinary biological products, chemical drugs, and traditional Chinese veterinary drugs. The company offers vaccines, antibodies, and medicines for swine and poultry, as well as disinfectants. Pulike Biological Engineering, Inc. was founded in 1995 and is headquartered in Luoyang, China.
Data Note
This record combines exchange-directory fields with selected profile enrichment. Treat market data, leadership and financial figures as directional unless verified against company filings, exchange announcements or the issuer's own disclosures.